{
  "id": 815,
  "text": "\\* [Conditional recommendation, low-certainty evidence] 33.WHO suggests that women living with HIV who have been treated for histologically confirmed CIN2/3 or adenocarcinoma in situ (AIS), or treated as a result of a positive screening test are retested at 12 months with HPV DNA testing when available, rather than with cytology or VIA or co-testing, and, if negative, are retested again at 12 months and, if negative again, move to the recommended regular screening interval.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: \\* [Conditional recommendation, low-certainty evidence] 33.WHO suggests that women living with HIV who have been treated for histologically confirmed CIN2/3 or adenocarcinoma in situ (AIS), or treated as a result of a positive screening test are retested at 12 months with HPV DNA testing when available, rather than with cytology or VIA or co-testing, and, if negative, are retested again at 12 mont\n\n<question>: ",
  "ChatGPT_response_0": "根据世界卫生组织的建议，女性HIV感染者在被治疗后应当使用HPV DNA测试进行再测试，而不是细胞学检查或视觉宫颈上皮鉴别检查。特别是针对已经确认有组织学CIN2/3或腺癌原位癌(AIS)的患者，或是由于阳性筛查结果而接受治疗的患者，推荐在12个月后重新进行HPV DNA测试。若结果为阴性，则应在12个月后再次复查，如果再次为阴性，则应按照建议的定期筛查间隔进行后续的检测。",
  "query": "在何种情况下，女性HIV感染者应该进行HPV DNA测试而不是细胞学检查或视觉宫颈上皮鉴别检查？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在何种情况下，女性HIV感染者应该进行HPV DNA测试而不是细胞学检查或视觉宫颈上皮鉴别检查？\n\n<reference text>: \\* [Conditional recommendation, low-certainty evidence] 33.WHO suggests that women living with HIV who have been treated for histologically confirmed CIN2/3 or adenocarcinoma in situ (AIS), or treated as a result of a positive screening test are retested at 12 months with HPV DNA testing when available, rather than with cytology or VIA or co-testing, and, if negative, are retested again at 12 months and, if negative again, move to the recommended regular screening interval.\n\n<reply>: ",
  "response": "根据世界卫生组织的建议，女性HIV感染者在被治疗后应当使用HPV DNA测试进行再测试，而不是细胞学检查或视觉宫颈上皮鉴别检查。特别是针对已经确认有组织学CIN2/3或腺癌原位癌(AIS)的患者，或是由于阳性筛查结果而接受治疗的患者，推荐在12个月后重新进行HPV DNA测试。若结果为阴性，则应在12个月后再次复查，如果再次为阴性，则应按照建议的定期筛查间隔进行后续的检测。"
}